Your browser doesn't support javascript.
loading
LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis.
Xie, Tao; Du, Kunpeng; Liu, Wei; Liu, Chunshan; Wang, Baiyao; Tian, Yunhong; Li, Rong; Huang, Xiaoting; Lin, Jie; Jian, Haifeng; Zhang, Jian; Yuan, Yawei.
Afiliación
  • Xie T; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Du K; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Liu W; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Liu C; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Wang B; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Tian Y; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Li R; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Huang X; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Lin J; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Jian H; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Zhang J; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China. zhangjian@gzhmu.edu.cn.
  • Yuan Y; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China. yuanyawei@gzhmu.edu.cn.
Br J Cancer ; 127(7): 1239-1253, 2022 10.
Article en En | MEDLINE | ID: mdl-35864158
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / MicroARNs Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / MicroARNs Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article